S. Korea approves Pfizer's COVID vaccine for ages 5-11

South Korean health officials have approved Pfizer’s COVID-19 vaccine for children aged 5 to 11, expanding the country’s immunization program in the face of a massive omicron outbreak that is driving up hospitalizations and deaths

Related posts